MARKET

AORT

AORT

Artivion, Inc.
NYSE
22.47
+0.08
+0.36%
After Hours: 22.47 0 0.00% 16:38 06/30 EDT
OPEN
22.12
PREV CLOSE
22.39
HIGH
22.67
LOW
21.30
VOLUME
913.62K
TURNOVER
--
52 WEEK HIGH
48.25
52 WEEK LOW
19.16
MARKET CAP
1.09B
P/E (TTM)
93.98
1D
5D
1M
3M
1Y
5Y
1D
Artivion: PMA Approval Supports Accelerating Growth And Margin Expansion
Seeking Alpha · 8h ago
Artivion Earns Buy Rating as AMDS Wins Broader FDA Approval; Analyst Reiterates $36 Price Target
TipRanks · 10h ago
Artivion Seeks To Tap $150 Million US Market Opportunity With FDA Approval
Benzinga · 1d ago
Why Artivion (AORT) Is Up 17.3% After Full FDA PMA Approval for AMDS Hybrid Prosthesis
Simply Wall St · 1d ago
Artivion Gains FDA PMA Approval For AMDS Hybrid Prosthesis In Treating Aortic Dissections
NASDAQ · 1d ago
Artivion: FDA Approval Expands AMDS Market Opportunity; Buy Rating Reiterated with Unchanged $44 Price Target
TipRanks · 1d ago
Analysts Are Bullish on These Healthcare Stocks: LifeMD (LFMD), Artivion (AORT)
TipRanks · 1d ago
Artivion Wins FDA Approval For AMDS Hybrid Prosthesis
NASDAQ · 1d ago
More
About AORT
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.

Webull offers Artivion Inc stock information, including NYSE: AORT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AORT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AORT stock methods without spending real money on the virtual paper trading platform.